<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR940817-2-00271</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=25 g=1 f=1 --> Chang LW. Mercury. In: Spencer PS, Schaumburg HH, eds. Experimental and Clinical Neurotoxicology. Baltimore: Williams and Wilkins, 1980:508&hyph;526.  <!-- PJG 0012 frnewline --> Chiba S, Ando K. Effects of chronic administration of kanamycin on conditioned suppression to auditory stimulus in rats. Jpn J Pharmacol 1976; 26:41&hyph;426.  <!-- PJG 0012 frnewline --> Choi DW. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1:623&hyph;634.  <!-- PJG 0012 frnewline --> Committee on Biological Markers of the National Research Council. Biological markers in environmental health research. Environ Health Perspect 1987; 74:3&hyph;9.  <!-- PJG 0012 frnewline --> Cone JE, Reeve GR, Landrigan PJ. Clinical and epidemiological studies. In: Tardiff RG, Rodricks JV, eds. Toxic Substances and Human Risk. New York: Plenum Press, 1987.  <!-- PJG 0012 frnewline --> Cook DG, Fahn S, Brait KA. Chronic manganese intoxication. Arch Neurol 1974; 30:59&hyph;71.  <!-- PJG 0012 frnewline --> Cory-Slechta DA. Behavioral measures of neurotoxicity. Neurotoxicology 1989; 10:271&hyph;296.  <!-- PJG 0012 frnewline --> Cory-Slechta DA. Bridging experimental animal and human behavioral toxicology studies. In: Russell RW, Flattau PE, Pope AM, eds. Behavioral Measures of Neurotoxicity. Washington, DC: National Academy Press, 1990.  <!-- PJG 0012 frnewline --> Costa LG. Interactions of neurotoxicants with neurotransmitter systems. Toxicology 1988; 49:359&hyph;366.  <!-- PJG 0012 frnewline --> Costa LG, Kaylor G, Murphy SD. In vitro and in vivo modulation of cholinergic muscarinic receptors in rat lymphocytes and brain by cholinergic agents. Int J Immunopharmacol 1990; 8:1267&hyph;75.  <!-- PJG 0012 frnewline --> Creason JP. Data evaluation and statistical analysis of functional observational battery data using a linear models approach. J Am Coll Toxicol 1989; 8:157&hyph;169.  <!-- PJG 0012 frnewline --> Crofton KM. Reflex modification and the detection of toxicant-induced auditory dysfunction. Neurotoxicol Teratol 1990; 12:461&hyph;468.  <!-- PJG 0012 frnewline --> Crook T, Ferris S, Bartus R, eds. Assessment in Geriatric Psychopharmacology. New Canaan, NY: Mark Powley Associates, 1983.  <!-- PJG 0012 frnewline --> Crump KS. A new method for determining allowable daily intakes. Fund Appl Toxicol 1984; 4:854&hyph;871.  <!-- PJG 0012 frnewline --> Cushner IM. Maternal behavior and perinatal risks: alcohol, smoking, and drugs. Ann Rev Pub Health 1981; 2:201&hyph;218.  <!-- PJG 0012 frnewline --> Damstra T, Bondy SC. The current status and future of biochemical assays for neurotoxicity. In: Spencer PS, Schaumburg HH, eds. Experimental and Clinical Neurotoxicity. Baltimore: Williams and Wilkins, 1980:820&hyph;833.  <!-- PJG 0012 frnewline --> Davies PW. The action potential. In: Mountcastle VB, ed. Medical Physiology, 12th edition. St. Louis: C.V. Mosby, 1968:1094&hyph;1120.  <!-- PJG 0012 frnewline --> Davis CS, Richardson RJ. Organophosphorous compounds. In: Spencer PS, Schaumburg HH, eds. Experimental and Clinical Neurotoxicology. Baltimore: Williams and Wilkins, 1980:527&hyph;544.  <!-- PJG 0012 frnewline --> Denny-Brown D, Dawson DM, Tyler HR. Handbook of Neurological Examination and Case Recording (3rd ed). Cambridge: Harvard University Press, 1982.  <!-- PJG 0012 frnewline --> Dews PB. On the assessment of risk. In: Krasnegor N, Gray J, Thompson T, eds. Developmental Behavioral Pharmacology. Hillsdale, NJ: Lawrence Erlbaum Associates, 1986:53&hyph;65.  <!-- PJG 0012 frnewline --> Dick, RB. Short duration exposure to organic solvents: the relationship between neurobehavioral test results and other indicators. Neurotoxicol. Teratol. 1988; 10:35&hyph;50.  <!-- PJG 0012 frnewline --> Dick RB, Johnson BL. Human experimental studies. In: Annau Z, ed. Neurobehavioral Toxicology. Baltimore: Johns Hopkins University Press, 1986. Dick RB, Bhattacharya A, Shukla R. Use of a computerized postural sway measurement system for neurobehavioral toxicology. Neurotoxicol Teratol 1990; 12:1&hyph;6.  <!-- PJG 0012 frnewline --> Dick, RB, Krieg, EF, Setzer, J, Taylor, B. Neurobehavioral effects from acute exposure to methyl isobutyl ketone and methyl ethyl ketone. Fund. Appl. Toxicol. 1992; 19:453&hyph;473.  <!-- PJG 0012 frnewline --> Domjan M, Burkhard B. The Principles of Learning and Memory. Monterey, CA: Cole, 1986.  <!-- PJG 0012 frnewline --> Dourson ML, Stara JF. Regulatory history and experimental support of uncertainty (safety) factors. Regul Toxicol Pharmacol 1983; 3:224&hyph;238.  <!-- PJG 0012 frnewline --> Dyer RS. Macrophysiological assessment of organometal neurotoxicity. In: Tilson H, Sparber SB, eds. Neurotoxicants and Neurobiological Function. New York: Wiley, 1987:137&hyph;184.  <!-- PJG 0012 frnewline --> Dyer RS, Howell WE. Triethyltin: ambient temperature alters visual system toxicity. Neurobehav Toxicol Teratol 1982; 4:267&hyph;271.  <!-- PJG 0012 frnewline --> Eccles CU. EEG correlates of neurotoxicity. Neurotoxicol Teratol 1988; 10:423&hyph;428.  <!-- PJG 0012 frnewline --> Eckerman DA, Bushnell PJ. The neurotoxicology of cognition: Attention, learning and memory. In: Tilson H, Mitchell CL, eds. Neurotoxicology. New York: Raven Press, 1992:213&hyph;270.  <!-- PJG 0012 frnewline --> Eckerman DA, Caroll JB, Foree D, Gullion CM, Lansman M, Long ER, Waller MB, Wallsten TS. An approach to brief field testing for neurotoxicity. Neurobehav Toxicol Teratol 1985; 7:387&hyph;393.  <!-- PJG 0012 frnewline --> Ecobichon DJ, Joy RM. Pesticides and Neurologic Disease. Boca Raton: CRC Press, 1982.  <!-- PJG 0012 frnewline --> Fechter LD, Young JS. Discrimination of auditory from non-auditory toxicity by reflex modification audiometry: effects of triethyltin. Toxicol Appl Pharmacol 1983; 70:216&hyph;227.  <!-- PJG 0012 frnewline --> Festing MFW. Genetic factors in neurotoxicology and neuropharmacology: a critical evaluation of the use of genetics as a research tool. Experientia 1991; 12:1877&hyph;1888.  <!-- PJG 0012 frnewline --> Fisher F. Neurotoxicology and government regulation of chemicals in the United States. In: Spencer PS, Schaumburg HH, eds. Experimental and Clinical Neurotoxicology. Baltimore: Williams and Wilkins, 1980:874&hyph;882.  <!-- PJG 0012 frnewline --> Food and Drug Administration Advisory Committee on Protocols for Safety Evaluation: Panel on carcinogenesis report on cancer testing in the safety evaluation of food additives and pesticides. Toxicol Appl Pharmacol 1971; 20:419&hyph;438.  <!-- PJG 0012 frnewline --> Fowler SC. Force and duration of operant response and dependent variables in behavioral pharmacology. In: Thompson T, Dews PB, eds. Advances in Behavioral Pharmacology. New York: Erlbaum, 1987.  <!-- PJG 0012 frnewline --> Freed DM, Kandel E. Long-term occupational exposure and the diagnosis of dementia. Neurotoxicology 1988; 9:391&hyph;400.  <!-- PJG 0012 frnewline --> Friedel RO. Pharmacokinetics in the geropsychiatric patient. In: Lipton, M., Usdin, E., Killam, K., eds. Psychopharmacology: A Generation of Progress. New York: Raven Press, 1978.  <!-- PJG 0012 frnewline --> Friedlander BR, Hearn HT. Epidemiologic considerations in studying neurotoxic disease. In: Spencer PS, Schaumburg HH, eds. Experimental and Clinical Neurotoxicology. Baltimore: Williams and Wilkins, 1980:650&hyph;662.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            